- Home
- BSTZ vs HRMY Comparison
BSTZ vs HRMY Comparison
Compare BSTZ & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSTZ
- HRMY
- Stock Information
- Founded
- BSTZ 2019
- HRMY 2017
- Country
- BSTZ United States
- HRMY United States
- Employees
- BSTZ N/A
- HRMY N/A
- Industry
- BSTZ Trusts Except Educational Religious and Charitable
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- BSTZ Finance
- HRMY Health Care
- Exchange
- BSTZ Nasdaq
- HRMY Nasdaq
- Market Cap
- BSTZ 1.6B
- HRMY 1.9B
- IPO Year
- BSTZ N/A
- HRMY 2020
- Fundamental
- Price
- BSTZ $20.98
- HRMY $33.23
- Analyst Decision
- BSTZ
- HRMY Buy
- Analyst Count
- BSTZ 0
- HRMY 9
- Target Price
- BSTZ N/A
- HRMY $47.00
- AVG Volume (30 Days)
- BSTZ 303.2K
- HRMY 1.2M
- Earning Date
- BSTZ 01-01-0001
- HRMY 10-29-2024
- Dividend Yield
- BSTZ 8.31%
- HRMY N/A
- EPS Growth
- BSTZ N/A
- HRMY N/A
- EPS
- BSTZ 0.71
- HRMY 2.11
- Revenue
- BSTZ N/A
- HRMY $681,879,000.00
- Revenue This Year
- BSTZ N/A
- HRMY $24.63
- Revenue Next Year
- BSTZ N/A
- HRMY $18.04
- P/E Ratio
- BSTZ $26.69
- HRMY $15.69
- Revenue Growth
- BSTZ N/A
- HRMY 25.83
- 52 Week Low
- BSTZ $14.11
- HRMY $28.14
- 52 Week High
- BSTZ $19.43
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- BSTZ 60.55
- HRMY 45.24
- Support Level
- BSTZ $20.51
- HRMY $32.35
- Resistance Level
- BSTZ $21.10
- HRMY $33.66
- Average True Range (ATR)
- BSTZ 0.30
- HRMY 1.20
- MACD
- BSTZ -0.05
- HRMY -0.12
- Stochastic Oscillator
- BSTZ 63.60
- HRMY 20.69
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.